Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ebenezer Daniel

Showing results (101-110 of 144) with videos related to

Pageof 15
Sort By:
Ophthalmology. Retina|April 25, 2019
Distribution of OCT Features within Areas of Macular Atrophy or Scar after 2 Years of Anti-VEGF Treatment for Neovascular AMD in CATTCynthia A Toth, Vincent Tai, Maxwell Pistilli, et al.
American Journal of Ophthalmology|June 27, 2008
Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidenceJohn H Kempen, Sapna Gangaputra, Ebenezer Daniel, et al.
Ophthalmology. Glaucoma|February 13, 2022
Prevalence and Factors Associated with Optic Disc Tilt in the Primary Open-Angle African American Glaucoma Genetics StudyEbenezer Daniel, Victoria Addis, Maureen G Maguire, et al.
JAMA Ophthalmology|May 31, 2014
Sustained visual acuity loss in the comparison of age-related macular degeneration treatments trialsGui-shuang Ying, Benjamin J Kim, Maureen G Maguire, et al.
Ophthalmology|October 14, 2014
Outcomes of eyes with lesions composed of >50% blood in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT)Michael M Altaweel, Ebenezer Daniel, Daniel F Martin, et al.
Ophthalmology|October 16, 2012
Risk factors for loss of visual acuity among patients with uveitis associated with juvenile idiopathic arthritis: the Systemic Immunosuppressive Therapy for Eye Diseases StudyAnthony C Gregory, John H Kempen, Ebenezer Daniel, et al.
Vision (Basel, Switzerland)|April 23, 2024
Features Associated with Visible Lamina Cribrosa Pores in Individuals of African Ancestry with Glaucoma: Primary Open-Angle African Ancestry Glaucoma Genetics (POAAGG) StudyJalin A Jordan, Ebenezer Daniel, Yineng Chen, et al.
Ophthalmology|December 25, 2009
Cyclosporine for ocular inflammatory diseasesR Oktay Kaçmaz, John H Kempen, Craig Newcomb, et al.
American Journal of Ophthalmology|August 19, 2008
Ocular inflammation in Behçet disease: incidence of ocular complications and of loss of visual acuityR Oktay Kaçmaz, John H Kempen, Craig Newcomb, et al.
Ophthalmology. Retina|May 4, 2019
Linking OCT, Angiographic, and Photographic Lesion Components in Neovascular Age-Related Macular DegenerationCynthia A Toth, Vincent Tai, Stephanie J Chiu, et al.
Pageof 15

Showing results (101-110 of 144) with videos related to

Sort By:
Pageof 15
Ophthalmology. Retina|April 25, 2019
Distribution of OCT Features within Areas of Macular Atrophy or Scar after 2 Years of Anti-VEGF Treatment for Neovascular AMD in CATTCynthia A Toth, Vincent Tai, Maxwell Pistilli, et al.
American Journal of Ophthalmology|June 27, 2008
Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidenceJohn H Kempen, Sapna Gangaputra, Ebenezer Daniel, et al.
Ophthalmology. Glaucoma|February 13, 2022
Prevalence and Factors Associated with Optic Disc Tilt in the Primary Open-Angle African American Glaucoma Genetics StudyEbenezer Daniel, Victoria Addis, Maureen G Maguire, et al.
JAMA Ophthalmology|May 31, 2014
Sustained visual acuity loss in the comparison of age-related macular degeneration treatments trialsGui-shuang Ying, Benjamin J Kim, Maureen G Maguire, et al.
Ophthalmology|October 14, 2014
Outcomes of eyes with lesions composed of >50% blood in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT)Michael M Altaweel, Ebenezer Daniel, Daniel F Martin, et al.
Ophthalmology|October 16, 2012
Risk factors for loss of visual acuity among patients with uveitis associated with juvenile idiopathic arthritis: the Systemic Immunosuppressive Therapy for Eye Diseases StudyAnthony C Gregory, John H Kempen, Ebenezer Daniel, et al.
Vision (Basel, Switzerland)|April 23, 2024
Features Associated with Visible Lamina Cribrosa Pores in Individuals of African Ancestry with Glaucoma: Primary Open-Angle African Ancestry Glaucoma Genetics (POAAGG) StudyJalin A Jordan, Ebenezer Daniel, Yineng Chen, et al.
Ophthalmology|December 25, 2009
Cyclosporine for ocular inflammatory diseasesR Oktay Kaçmaz, John H Kempen, Craig Newcomb, et al.
American Journal of Ophthalmology|August 19, 2008
Ocular inflammation in Behçet disease: incidence of ocular complications and of loss of visual acuityR Oktay Kaçmaz, John H Kempen, Craig Newcomb, et al.
Ophthalmology. Retina|May 4, 2019
Linking OCT, Angiographic, and Photographic Lesion Components in Neovascular Age-Related Macular DegenerationCynthia A Toth, Vincent Tai, Stephanie J Chiu, et al.
Pageof 15